miR-187 is involved in the regulation of ovarian cancer by targeting disabled homolog-2, which supposedly promotes tumor progression in advanced cancers via epithelial–mesenchymal transition [42,43]. The gene discussed is DAB2; the disease is ovarian carcinoma.